AIM: Although arterial closure devices are in use for over a decade, there have been no specific study to assess the use of the same in antegrade puncture. MATERIAL AND METHOD: Consecutive patients undergoing antegrade puncture for peripheral vascular disease in a single centre performed by a single operator were included in this study. The notes and the angiograms were reviewed retrospectively for possible complications and the severity of disease. RESULT: Over a 25-month period, 21 patients with antegrade puncture had Angioseal deployed for haemostasis. Post-procedure complications recorded from the case notes showed one episode of haematoma formation and one case of worsening ischaemia. The severity of the disease at the puncture site did not influence the outcome. CONCLUSION: Use of Angioseal is safe and effective in antegrade punctures for peripheral vascular disease. The result is independent of the severity of disease at the puncture site.
AIM: Although arterial closure devices are in use for over a decade, there have been no specific study to assess the use of the same in antegrade puncture. MATERIAL AND METHOD: Consecutive patients undergoing antegrade puncture for peripheral vascular disease in a single centre performed by a single operator were included in this study. The notes and the angiograms were reviewed retrospectively for possible complications and the severity of disease. RESULT: Over a 25-month period, 21 patients with antegrade puncture had Angioseal deployed for haemostasis. Post-procedure complications recorded from the case notes showed one episode of haematoma formation and one case of worsening ischaemia. The severity of the disease at the puncture site did not influence the outcome. CONCLUSION: Use of Angioseal is safe and effective in antegrade punctures for peripheral vascular disease. The result is independent of the severity of disease at the puncture site.
Authors: Jim A Reekers; Stefan Müller-Hülsbeck; Martin Libicher; Eli Atar; Jens Trentmann; Pierre Goffette; Jan Borggrefe; Kamil Zeleňák; Pieter Hooijboer; Anna-Maria Belli Journal: Cardiovasc Intervent Radiol Date: 2010-10-28 Impact factor: 2.740